Title: A phase 1 study of the pharmacokinetics of nucleoside analog trifluridine and thymidine phosphorylase inhibitor tipiracil (components of TAS-102) vs trifluridine alone.
Journal: Investigational new drugs 20170101
Title: Emerging combination therapies for metastatic colorectal cancer - impact of trifluridine/tipiracil.
Journal: Cancer management and research 20170101
Title: Effect of food on the pharmacokinetics of TAS-102 and its efficacy and safety in patients with advanced solid tumors.
Journal: Cancer science 20160501
Title: Trifluridine/Tipiracil (Lonsurf) for the Treatment of Metastatic Colorectal Cancer.
Journal: P & T : a peer-reviewed journal for formulary management 20160501
Title: Human mass balance study of TAS-102 using (14)C analyzed by accelerator mass spectrometry.
Journal: Cancer chemotherapy and pharmacology 20160301
Title: TAS-102, a novel antitumor agent: a review of the mechanism of action.
Journal: Cancer treatment reviews 20151101
Title: Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models.
Journal: Oncology reports 20141201
Title: TAS-102: more than an antimetabolite.
Journal: The Lancet. Oncology 20121201
Title: Fluorophosphonylated nucleoside derivatives as new series of thymidine phosphorylase multisubstrate inhibitors.
Journal: Journal of medicinal chemistry 20120322
Title: Platelet derived endothelial cell growth factor/thymidine phosphorylase enhanced human IgE production.
Journal: Allergology international : official journal of the Japanese Society of Allergology 20110301
Title: The role of phosphate in the action of thymidine phosphorylase inhibitors: Implications for the catalytic mechanism.
Journal: Bioorganic & medicinal chemistry letters 20100301
Title: [Influence of the thymidine phosphorylase (platelet-derived endothelial cell growth factor) on tumor angiogenesis. Catalytic activity of enzyme inhibitors].
Journal: Postepy biochemii 20100101
Title: Discovery of 5-substituted-6-chlorouracils as efficient inhibitors of human thymidine phosphorylase.
Journal: Journal of medicinal chemistry 20071129
Title: Therapeutic potential of the dual-targeted TAS-102 formulation in the treatment of gastrointestinal malignancies.
Journal: Cancer science 20070601
Title: Thymidine phosphorylase from Escherichia coli: tight-binding inhibitors as enzyme active-site titrants.
Journal: Journal of enzyme inhibition and medicinal chemistry 20060201
Title: Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma.
Journal: British journal of cancer 20050509
Title: Pharmacokinetic modeling of species-dependent enhanced bioavailability of trifluorothymidine by thymidine phosphorylase inhibitor.
Journal: Drug metabolism and pharmacokinetics 20040601
Title: Thymidine kinase and thymidine phosphorylase level as the main predictive parameter for sensitivity to TAS-102 in a mouse model.
Journal: Oncology reports 20040201
Title: Crystal structure of human thymidine phosphorylase in complex with a small molecule inhibitor.
Journal: Structure (London, England : 1993) 20040101
Title: Identification of a novel class of inhibitor of human and Escherichia coli thymidine phosphorylase by in silico screening.
Journal: Bioorganic & medicinal chemistry letters 20031103
Title: Thymidine phosphorylase and 2-deoxyribose stimulate human endothelial cell migration by specific activation of the integrins alpha 5 beta 1 and alpha V beta 3.
Journal: The Journal of biological chemistry 20030523
Title: Design of novel N-(2,4-dioxo-1,2,3,4-tetrahydro-thieno[3,2-d]pyrimidin-7-yl)-guanidines as thymidine phosphorylase inhibitors, and flexible docking to a homology model.
Journal: Bioorganic & medicinal chemistry letters 20030106
Title: Significance of platelet-derived endothelial cell growth factor in the angiogenesis of human gastric cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 19980201
Title: Lee SJ, et al. Thymidine phosphorylase influences [(18)Ffluorothymidine uptake in cancer cells and patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1327-35.
Title: Raedler LA. Lonsurf (Trifluridine plus Tipiracil): A New Oral Treatment Approved for Patients with Metastatic Colorectal Cancer. Am Health Drug Benefits. 2016 Mar;9(Spec Feature):97-100.
Title: Tanaka N, et al. Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models. Oncol Rep. 2014 Dec;32(6):2319-26.
